SCHEMBL31094705

SCHEMBL31094705

CC1CN(C(=O)OC(C)(C)C)CCC1=C(F)F

nearest known ligand 0.42

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
USP2 O75604 1/20 0.41
SMN1; SMN2 Q16637 1/20 0.41
ESR2 Q92731 1/20 0.41
NR1H2 P55055 2/20 0.40
MAPT P10636 2/20 0.39
MEN1 O00255 1/20 0.39
ALDH1A1 P00352 1/20 0.39
KMT2A Q03164 1/20 0.39
HPGD P15428 1/20 0.39
GPR119 Q8TDV5 2/20 0.38
ADORA1 P30542 1/20 0.38
RECQL P46063 1/20 0.38
EPHX1 P07099 1/20 0.38
KDM4E B2RXH2 1/20 0.37
THRB P10828 1/20 0.37
PTPN2 P17706 1/20 0.37
PTPN1 P18031 1/20 0.37
PTPN6 P29350 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30841276 1.00 USP2 (0.41) USP2SMN1; SMN2ESR2NR1H2MAPT
SCHEMBL30841148 0.93 USP2 (0.39) USP2SMN1; SMN2ESR2NR1H2MAPT
SCHEMBL30840939 0.83 NR1H2 (0.40) USP2SMN1; SMN2ESR2NR1H2MAPT
SCHEMBL28441771 0.81 USP2 (0.44) USP2SMN1; SMN2ESR2NR1H2MAPT
SCHEMBL21241481 0.81 USP2 (0.44) USP2SMN1; SMN2ESR2NR1H2MAPT
SCHEMBL104498 0.81 USP2 (0.44) USP2SMN1; SMN2ESR2NR1H2MAPT
Ammonia Solution, Strong SCHEMBL28305195 0.80 USP2 (0.42) USP2SMN1; SMN2ESR2NR1H2MAPT
SCHEMBL2337486 0.80 USP2 (0.42) USP2SMN1; SMN2ESR2NR1H2MAPT
SCHEMBL31708282 0.77 ALDH1A1 (0.36) USP2SMN1; SMN2NR1H2ALDH1A1HPGD
SCHEMBL15494496 0.76 HPGD (0.46) USP2SMN1; SMN2NR1H2MAPTMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024208228-A1 NOVEL COMPOUNDS, COMPOSITIONS COMPRISING THE SAME AND USES THEREOF NUPHASE THERAPEUTICS (HANGZHOU) LIMITED., CO. (CN) 2024-10-10 WO disclosed